Suchergebnisse - "Song, Guangjun"

PubPharm (28)

1

GSDMD induces hepatocyte pyroptosis to trigger alcoholic hepatitis through modulating mitochondrial dysfunction

enthalten in: Cell division | 2024

von Xie, Y. | Wang, Z. | Song, G. | +2

2

GSDMD induces hepatocyte pyroptosis to trigger alcoholic hepatitis through modulating mitochondrial dysfunction

enthalten in: Cell division | 2024

von Xie, Y. | Wang, Z. | Song, G. | +2

3

HBV pregenome RNA as a predictor of spontanous HBeAg seroconversion in HBeAg-positive chronic hepatitis B patients

enthalten in: BMC gastroenterology | 2023

von Song, G. | Yang, R. | Jin, Q. | +4

4

Response of microalgae size-class structure to nutrients differences in northern Yellow Sea, China

enthalten in: Environmental science and pollution research international | 2023

von Song, L. | Liu, Y. | Song, G. | +2

5

A bibliometric analysis of worldwide cancer research using machine learning methods

enthalten in: Cancer innovation | 2023

von Lin, L. | Liang, L. | Wang, M. | +4

6

Clinical efficacy of Chinese herbal footbath plus traditional Chinese medicine decoction in diabetic peripheral neuropathy

enthalten in: American journal of translational research | 2023

von Song, G. | Zhuang, J. | Wang, X.

7

Combining the HBcrAg decline and HBV mutations predicts spontaneous HBeAg seroconversion in chronic hepatitis B patients during the immune clearance phase

enthalten in: Journal of medical virology | 2022

von Xie, Y. | Ma, H. | Feng, B. | +1

8

Combining the HBcrAg decline and HBV mutations predicts spontaneous HBeAg seroconversion in chronic hepatitis B patients during the immune clearance phase

enthalten in: Journal of Medical Virology | 2022

von Xie, Y. | Ma, H. | Feng, B. | +1

9

Safety and efficacy of coblopasvir and sofosbuvir in patients with genotypes 1, 2, 3 and 6 HCV infections without or with compensated cirrhosis

enthalten in: Journal of viral hepatitis | 2020

von Rao, H. | Song, G. | Li, G. | +14

10

Clinical efficacy and safety of sofosbuvir tablets combined with ribavirin in treatment of treatment-nave patients with genotype 2 chronic hepatitis C virus infection

in: Linchuang Gandanbing Zazhi | 2020

von SONG Guangjun